• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

叶酸靶向 pH 敏感硼替佐米缀合物用于癌症治疗。

Folate-targeted pH-sensitive bortezomib conjugates for cancer treatment.

机构信息

Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, Texas 77843, USA.

出版信息

Chem Commun (Camb). 2019 Apr 4;55(29):4254-4257. doi: 10.1039/c9cc01344j.

DOI:10.1039/c9cc01344j
PMID:30901007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6543544/
Abstract

In this study, a folate-targeted pH-sensitive bortezomib conjugate was developed for cancer-specific drug delivery and therapy. The conjugate showed improved cellular uptake, penetration, and anticancer activity compared to free bortezomib, a bortezomib-mannitol derivative, and a PEGylated bortezomib conjugate in folate receptor overexpressing cancer cells and their 3D spheroids.

摘要

在这项研究中，开发了一种叶酸靶向 pH 敏感硼替佐米缀合物，用于癌症特异性药物递送和治疗。与游离硼替佐米、硼替佐米甘露醇衍生物以及叶酸受体过表达癌细胞及其 3D 球体中的聚乙二醇化硼替佐米缀合物相比，该缀合物显示出改善的细胞摄取、穿透和抗癌活性。

相似文献

1
Folate-targeted pH-sensitive bortezomib conjugates for cancer treatment.叶酸靶向 pH 敏感硼替佐米缀合物用于癌症治疗。
Chem Commun (Camb). 2019 Apr 4;55(29):4254-4257. doi: 10.1039/c9cc01344j.
2
Boronate-crosslinked polysaccharide conjugates for pH-responsive and targeted drug delivery.硼酸酯键交联多糖缀合物用于 pH 响应型和靶向药物递送。
Chem Commun (Camb). 2019 Jan 25;55(8):1164-1167. doi: 10.1039/c8cc09956a. Epub 2019 Jan 11.
3
Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.利用叶酸靶向和肿瘤微环境敏感多肽的组合将化疗药物递送到癌细胞中。
Biomaterials. 2013 May;34(16):4137-4149. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1.
4
Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.用于药物递送的多功能pH响应型叶酸受体介导的聚合物纳米颗粒
J Biomed Nanotechnol. 2016 Jul;12(7):1453-62. doi: 10.1166/jbn.2016.2287.
5
Encapsulation and pH-responsive release of bortezomib by dopamine grafted hyaluronate nanogels.通过多巴胺接枝透明质酸纳米凝胶对硼替佐米进行包封和 pH 响应释放。
Int J Biol Macromol. 2021 Jul 31;183:369-378. doi: 10.1016/j.ijbiomac.2021.04.161. Epub 2021 Apr 28.
6
Screening of Polymer-Based Drug Delivery Vehicles Targeting Folate Receptors in Triple-Negative Breast Cancer.基于聚合物的药物传递载体筛选用于三阴性乳腺癌的叶酸受体靶向
J Vasc Interv Radiol. 2020 Nov;31(11):1866-1873.e2. doi: 10.1016/j.jvir.2020.05.010.
7
Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery.智能 pH 和还原双重响应叶酸-PEG 涂层聚合物脂质体用于肿瘤触发的靶向药物递送。
Nanoscale. 2014 Jul 7;6(13):7635-42. doi: 10.1039/c4nr00843j.
8
Self-assembly and self-delivery nanodrug of bortezomib: a simple approach to achieve the trade-off between functionality and druggability.硼替佐米自组装和自递药纳米药物：一种在功能和可药性之间实现权衡的简单方法。
J Mater Chem B. 2019 Dec 21;7(47):7490-7493. doi: 10.1039/c9tb02174d. Epub 2019 Nov 25.
9
Folate-polyethylene glycol conjugated carboxymethyl chitosan for tumor-targeted delivery of 5-fluorouracil.叶酸-聚乙二醇偶联羧甲基壳聚糖用于 5-氟尿嘧啶的肿瘤靶向递送。
Mol Med Rep. 2014 Mar;9(3):786-92. doi: 10.3892/mmr.2014.1917. Epub 2014 Jan 23.
10
Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.点击化学策略合成的叶酸偶联β-环糊精及其用于肿瘤靶向药物传递。
J Biomed Mater Res A. 2012 Sep;100(9):2441-9. doi: 10.1002/jbm.a.34169. Epub 2012 May 5.

引用本文的文献

1
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy.用于肿瘤治疗的不同靶向配体介导的药物递送系统
Pharmaceutics. 2024 Feb 7;16(2):248. doi: 10.3390/pharmaceutics16020248.
2
Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials.癌症纳米医学：新兴策略与治疗潜能。
Molecules. 2023 Jun 30;28(13):5145. doi: 10.3390/molecules28135145.
3
In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib.原位电化学评价 dsDNA 与蛋白酶体抑制剂抗癌药物硼替佐米的相互作用。

本文引用的文献

1
Modular Assembly of Reversible Multivalent Cancer-Cell-Targeting Drug Conjugates.模块化组装可逆多价癌症细胞靶向药物偶联物。
Angew Chem Int Ed Engl. 2017 Aug 1;56(32):9346-9350. doi: 10.1002/anie.201703492. Epub 2017 Jul 10.
2
Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate.通过刺激响应型多功能聚合物-药物偶联物增强癌症靶向和抗癌活性。
J Control Release. 2015 Aug 28;212:94-102. doi: 10.1016/j.jconrel.2015.06.024. Epub 2015 Jun 22.
3
Proteasome inhibitors.蛋白酶体抑制剂。
Molecules. 2023 Apr 6;28(7):3277. doi: 10.3390/molecules28073277.
4
Targeted Delivery Methods for Anticancer Drugs.抗癌药物的靶向递送方法
Cancers (Basel). 2022 Jan 26;14(3):622. doi: 10.3390/cancers14030622.
5
Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations.硼替佐米及其基于纳米制剂的应用进展。
Biomolecules. 2021 Dec 30;12(1):51. doi: 10.3390/biom12010051.
6
Graphene quantum dots decorated with imatinib for leukemia treatment.用伊马替尼修饰的石墨烯量子点用于白血病治疗。
J Drug Deliv Sci Technol. 2021 Feb;61. doi: 10.1016/j.jddst.2020.102117. Epub 2020 Sep 28.
7
Targeting Tumor-Associated Macrophages by MMP2-Sensitive Apoptotic Body-Mimicking Nanoparticles.靶向肿瘤相关巨噬细胞的 MMP2 敏感型凋亡体模拟纳米颗粒。
ACS Appl Mater Interfaces. 2020 Nov 25;12(47):52402-52414. doi: 10.1021/acsami.0c15983. Epub 2020 Nov 10.
Biochem Pharmacol. 2015 Jul 1;96(1):1-9. doi: 10.1016/j.bcp.2015.04.008. Epub 2015 Apr 29.
4
Acid-labile boronate-bridged dextran-bortezomib conjugate with up-regulated hypoxic tumor suppression.具有上调的缺氧肿瘤抑制作用的酸不稳定硼酸酯桥联葡聚糖-硼替佐米共轭物
Chem Commun (Camb). 2015 Apr 21;51(31):6812-5. doi: 10.1039/c5cc01371b.
5
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation.硼替佐米通过刺激细胞外信号调节激酶（ERK）磷酸化来阻断自噬流，从而增强癌细胞死亡。
Cell Death Dis. 2014 Nov 6;5(11):e1510. doi: 10.1038/cddis.2014.468.
6
Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety.载 MMP2 敏感型 PEG-药物偶联物和穿膜肽的纳米制剂增强抗癌活性。
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17047-52. doi: 10.1073/pnas.1304987110. Epub 2013 Sep 23.
7
Structural basis for molecular recognition of folic acid by folate receptors.叶酸受体对叶酸的分子识别的结构基础。
Nature. 2013 Aug 22;500(7463):486-9. doi: 10.1038/nature12327. Epub 2013 Jul 14.
8
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias.硼替佐米与多药转运体的相互作用：对晚期多发性骨髓瘤和其他肿瘤治疗应用的影响。
Cancer Chemother Pharmacol. 2013 May;71(5):1357-68. doi: 10.1007/s00280-013-2136-7. Epub 2013 Apr 16.
9
Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles.高容量聚（2-恶唑啉）胶束中多种化疗药物的协同组合
Mol Pharm. 2012 Aug 6;9(8):2302-13. doi: 10.1021/mp300159u. Epub 2012 Jun 28.
10
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.叶酸受体-α靶向的卵巢癌术中肿瘤特异性荧光成像：首例人体研究结果。
Nat Med. 2011 Sep 18;17(10):1315-9. doi: 10.1038/nm.2472.